Sandra Zazo Hernández
Biologist, Coordinator of the Molecular Pathology Laboratory- Pathology Department
- Hospital Universitario Fundación Jiménez Díaz
Biologist in the Department of Pathology at the Jiménez Díaz Foundation (since 2016 to present)
Coordinator of the Biobank at the Jiménez Díaz Foundation (since 2011 to present)
Member of the Research Committee at the Jiménez Díaz Health Research Institute (since 2019 to present)
Member of the Ethics Committee for Research at the Jiménez Díaz Foundation (since 2019 to present)
Specialist Technician in the Department of Pathology at the Jiménez Díaz Foundation, Madrid (from 2011 to 2014)
Predoctoral Researcher at the Conchita Rábago Foundation (from 2008 to 2011)
Degree in Biological Sciences, Complutense University of Madrid - 2006
Expert in Clinical Laboratory certification from the Clinical Analysis School, a degree issued by the Complutense University of Madrid - 2007
Master's in Biobanks and the Use of Human Biological Samples in Biomedical Research, Catholic University of Valencia and the National Biobank Network - 2011
PhD in Biological Sciences from the Autonomous University of Madrid with the qualification "Cum Laude" - 2017
Techniques and Interpretation of Next-Generation Sequencing (NGS) on paraffin-embedded tissue samples and liquid biopsy samples in solid tumors to identify predictive and prognostic biomarkers
Techniques and Interpretation of Fluorescence In Situ Hybridization (FISH) for predictive biomarkers in solid tumors
Techniques and Interpretation of PCR-based studies, including real-time PCR, pyrosequencing, and Sanger Sequencing
Techniques and Interpretation of digital PCR studies in liquid biopsy samples
Validation and Optimization of new molecular techniques for biomarker identification in solid tumors
Participation in multidisciplinary committees, Molecular Committee
Participation in clinical sessions
Member of the Pathology Research Group, Cancer Area at IIS-FJD.
Participation in 23 competitive and private research projects since 2010:
PI24/00160: Preclinical and Clinical Characterization of the Role of LCOR and the Hippo Signaling Pathway in Resistance to Anti-HER2 Therapies in HER2-Positive Breast Cancer (AES2024-ISCIII)
PT23/00114: ISCIII Platforms Supporting R&D in Biomedicine and Health Sciences (Plataformas 2023-ISCIII)
PI21/00142: Prediction of Residual Disease After Neoadjuvant Therapy in HER2-Positive Breast Cancer and Identification of Strategies to Overcome Resistance (AES2021-ISCIII)
PT20/00141: Biobank Platform
Continuing Education in Molecular Pathology for residents and higher education students in TEAP (Technical Specialist in Clinical Analysis)
Training Courses in Precision Medicine for public/private entities
Author/Co-Author of over 73 articles in indexed scientific journals, totaling 1,692 citations (total publications in Q1 quartile: 20). H-index: 22.
Updated May 2025
Organizer of the "First Awareness Day on Biobanks in Cancer Research"
Coordinator of Module 3: "Immunohistochemical Studies and In Situ Hybridization. Updates in IHC, IF, and ISH Techniques. New Methodologies and Applications in Diagnosis" in the series of 5 online courses on Expert Procedures in the Pathology Laboratory. Organized by SEAP
Author/Co-Author of over 85 oral and poster scientific presentations at National and International Congresses and Conferences
Member of the Official College of Biologists of the Community of Madrid (COBCM) since 2017
Member of the Spanish Society of Pathology (SEAP) since 2017
Member of the Spanish Breast Cancer Research Group (GEICAM) since 2020
Certification as a Health Biologist granted by the General Council of Official Colleges of Biologists (2022).
Evaluator for the Quality Assurance Program of IHC-HER2, ISH-HER2, Mammary Pathology, and IHC-PD-L1 modules of the Spanish Society of Pathology.
Hospital Universitario Fundación Jiménez Díaz
Avda. Reyes Católicos, 2
28040 Madrid Madrid
